<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0001493152-22-004590</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Chan Heng Fai Ambrose -->
          <cik>0001261725</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>20</amendmentNo>
      <securitiesClassTitle>Common Stock, Par Value $0.001 Per Share</securitiesClassTitle>
      <dateOfEvent>04/15/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001750106</issuerCIK>
        <issuerCUSIP>02115D208</issuerCUSIP>
        <issuerName>Alset Inc.</issuerName>
        <address>
          <com:street1>4800 Montgomery Lane</com:street1>
          <com:street2>Suite 210</com:street2>
          <com:city>Bethesda</com:city>
          <com:stateOrCountry>MD</com:stateOrCountry>
          <com:zipCode>20814</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Heng Fai Ambrose Chan</personName>
          <personPhoneNum>011 65 6333 9181</personPhoneNum>
          <personAddress>
            <com:street1>9 Temasek Boulevard #16-04</com:street1>
            <com:street2>Suntec Tower Two</com:street2>
            <com:city>Singapore</com:city>
            <com:stateOrCountry>U0</com:stateOrCountry>
            <com:zipCode>038989</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001261725</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Heng Fai Ambrose Chan</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>U0</citizenshipOrOrganization>
        <soleVotingPower>7718742.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>7718742.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>7718742.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>65.8</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>Includes 3,875,506 shares of common stock held by HFE Holdings Limited, of which Mr. Chan has sole voting and investment power with respect to such shares. Percentage is based upon 11,735,119 shares of common stock outstanding as of April 17, 2025.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001756133</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>HFE Holdings Limited</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>K3</citizenshipOrOrganization>
        <soleVotingPower>3875506.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>3875506.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>3875506.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>33</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>Percentage is based upon 11,735,119 shares of common stock outstanding as of April 17, 2025.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, Par Value $0.001 Per Share</securityTitle>
        <issuerName>Alset Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>4800 Montgomery Lane</com:street1>
          <com:street2>Suite 210</com:street2>
          <com:city>Bethesda</com:city>
          <com:stateOrCountry>MD</com:stateOrCountry>
          <com:zipCode>20814</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>Heng Fai Ambrose Chan</filingPersonName>
        <principalBusinessAddress>9 Temasek Boulevard #14-06, Suntec Tower Two, Singapore 038989</principalBusinessAddress>
        <principalJob>Chairman and Chief Executive Officer, Alset Inc., 4800 Montgomery Lane Suite 210, Bethesda, MD 20814</principalJob>
        <hasBeenConvicted>None.</hasBeenConvicted>
        <convictionDescription>None.</convictionDescription>
        <citizenship>Singapore</citizenship>
      </item2>
      <item3>
        <fundsSource>On February 12, 2025, Mr. Chan acquired 20,244 shares of the Issuer's common stock at a weighted average purchase price of $1.07 per share.

On February 13, 2025, Mr. Chan acquired 50,000 shares of the Issuer's common stock at a weighted average purchase price of $1.23 per share. This transaction was executed in multiple trades at prices ranging from $1.16 to $1.29.

On April 15, 2025, the Board of Directors of Alset Inc. awarded Chairman and Chief Executive Officer Chan Heng Fai 1,000,000 restricted shares of the Company's common stock. The Shares were granted to Mr. Chan as compensation for services rendered to the Company pursuant to the Company's 2025 Incentive Compensation Plan, as adopted on March 17, 2025.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>All of the Issuer's securities owned by the Reporting Person have been acquired for investment purposes only. As of the date of this Schedule 13D, the Reporting Person has no present plans or proposals that relate to or would result in any of the actions required to be described in subsections (a) through (j) of Item 4 of Schedule 13D. The Reporting Person may, at any time, review or reconsider its positions with respect to the Issuer and formulate plans or proposals with respect to any of such matters, but have no present intention of doing so.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>7,718,742, 65.8%</percentageOfClassSecurities>
        <numberOfShares>7,718,742</numberOfShares>
        <transactionDesc>There were no other transactions effected in the last 60 days by the Reporting Person except for the transactions which are the subject of this Schedule 13D and are described herein and when (i) on January 22, 2025, Mr. Chan acquired 50,000 shares of the Issuer's common stock at a weighted average purchase price of $0.85; and when (ii) on January 27, 2025, Mr. Chan acquired 100,000 shares of the Issuer's common stock at a weighted average purchase price of $0.93.</transactionDesc>
      </item5>
      <item6>
        <contractDescription>None.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Joint Filing Agreement, by and between the Reporting Persons, incorporated by reference to Schedule 13D filed with the SEC on February 15, 2022.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Heng Fai Ambrose Chan</signatureReportingPerson>
        <signatureDetails>
          <signature>Heng Fai Ambrose Chan</signature>
          <title>Heng Fai Ambrose Chan/Individual</title>
          <date>04/17/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>HFE Holdings Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>Heng Fai Ambrose Chan</signature>
          <title>Heng Fai Ambrose Chan/Director, HFE Holdings Limited</title>
          <date>04/17/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
